Your session is about to expire
← Back to Search
Behavioral Weight Loss + Cardiac Rehab for Atrial Fibrillation and Obesity (BE-WEL in CR Trial)
N/A
Waitlist Available
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
18+ years
Obesity (i.e., BMI ≥30 kg/m2)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12-weeks
Awards & highlights
BE-WEL in CR Trial Summary
This trial will test whether adding behavioral weight-loss treatment to traditional cardiac rehabilitation helps people with atrial fibrillation and obesity experience relief from their symptoms.
Who is the study for?
This trial is for English-speaking adults over 18 with obesity (BMI ≥30) and symptomatic, documented atrial fibrillation that's not permanent. It's not for those with uncontrolled coronary artery disease, in another weight loss program, or scheduled for catheter ablation treatment.Check my eligibility
What is being tested?
The study tests a new behavioural weight-loss treatment added to cardiac rehabilitation (CR) for patients with atrial fibrillation and obesity. It includes supervised exercise sessions twice weekly and online group therapy classes focused on psychological strategies for weight loss.See study design
What are the potential side effects?
While the trial itself may not have direct side effects, participants might experience general discomforts from lifestyle changes such as muscle soreness from increased physical activity or stress related to behavior modification techniques.
BE-WEL in CR Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
My BMI is 30 or higher.
Select...
I have had at least 2 episodes of AF in the last 6 months or an AF episode that lasted 7 days or more.
BE-WEL in CR Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 12-weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12-weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Intervention Acceptability
Intervention Feasibility
Secondary outcome measures
AF-related quality of life
Atrial Fibrillation
Psychological Distress
+1 moreBE-WEL in CR Trial Design
1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
The intervention consists of a traditional 12-week outpatient CR program with added weekly behavioural weight loss classes.
Find a Location
Who is running the clinical trial?
University of CalgaryLead Sponsor
795 Previous Clinical Trials
874,565 Total Patients Enrolled
11 Trials studying Atrial Fibrillation
2,452 Patients Enrolled for Atrial Fibrillation
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I have had at least 2 episodes of AF in the last 6 months or an AF episode that lasted 7 days or more.You are currently taking part in a program to lose weight at the same time.I am scheduled for a procedure to treat my irregular heartbeat.My BMI is 30 or higher.My heart disease is not under control.I have had atrial fibrillation continuously for 3 years or more.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger